Science & Policy, The Future of Cancer Care: Watch Now

The American Cancer Society recently released gloomy numbers, showing that the number of new cancer cases in the United States is expected to surpass the 2 million mark for the first time.

Although medical advances have steadily reduced cancer deaths over the past 30 years, an increase in the number of cases of many common cancers is putting this progression at risk. More than 313,000 new breast cancer cases are predicted to occur in 2024.

Join us for The Hill’s Cancer Summit. Government officials, lawmakers, patient advocates, physicians and scientists will discuss how to accelerate critical research and equity with the goal of ending cancer.

The event is scheduled to begin at 8:30 a.m. ET.

Program segment:

bipartisan perspective (In a conversation with Bob Cusack, Editor-in-Chief, The Hill)

• Congressman John Joyce (R-Pennsylvania)co-sponsor of the ORPHAN Cures Act
• Congressman Wiley Nickell (D.N.C.)co-sponsor of the ORPHAN Cures Act

White House cancer updates (In a conversation with Bob Cusack, Editor-in-Chief, The Hill)

• Dr. Daniel Carnival, Cancer Moonshot, Deputy Assistant to the President.Deputy Director for Health Outcomes, White House Office of Science and Technology Policy

panel discussion: Reduce inequalities in cancer treatment (in a conversation with Bob Cusack, Editor-in-Chief, The Hill)

• Dr. Crystal DenlingerCEO of National Comprehensive Cancer Network (NCCN)
• Pam Traxel Senior Vice President, Alliance Development and Philanthropy, American Cancer Society Cancer Action Network
• maima carmoFounder and CEO of Tiger Lily Foundation

Sponsor’s perspective (in a conversation with Kathleen Koch, Contributing Editor, The Hill)

• Mohit Manrao Senior Vice President, Head of US Oncology, AstraZeneca

Industry perspective (In a conversation with Bob Cusack, Editor-in-Chief, The Hill)

• John CrowleyCEO and President, BIO

I have a question?Connect with us on social media @a_o_o_o_o_o_ Use #TheHillCancer

Sponsored by:

AstraZeneca is a science-driven, patient-focused pharmaceutical company. We are dedicated to transforming the future of health care by unlocking the power of science for people, society and the planet. At AstraZeneca, we have bold ambitions to deliver treatments for all forms of cancer. In collaboration with all stakeholders, we harness the power of science and innovation to deliver life-changing medicines. By understanding the complexity of cancer, we hope to revolutionize cancer treatment and increase our chances of saving lives around the world.Learn more about our oncology research here.